Overpatented, overpriced: How excessive pharmaceutical patenting is extending monopolies and driving up drug prices
This new report by our partner I-MAK analyzes the twelve best selling drugs in the United States and shows how...
Read more about Overpatented, overpriced: How excessive pharmaceutical patenting is extending monopolies and driving up drug prices
Dear Viiv, we’ve fixed your AIDS 2018 ‘letter’.
We thought ViiV’s large, expensive advert outside AIDS 2018 in Amsterdam needed some re-working. Such a shame to spend all...
Read more about Dear Viiv, we’ve fixed your AIDS 2018 ‘letter’.
Connect with us at AIDS 2018 – & increase access to HIV treatment!
Are you going to be at the International AIDS Conference (AIDS2018) in Amsterdam, or following from afar? Here’s how to...
Read more about Connect with us at AIDS 2018 – & increase access to HIV treatment!
Fixing the broken patent system: From Marrakech and back again
Marrakech was home to the signing of the TRIPS Agreement in 1995, an agreement that has been exploited by pharmaceutical...
Read more about Fixing the broken patent system: From Marrakech and back again
GSIPA2M: The Summit Highlights
Catch up on the activity from our inaugural Global Summit on Intellectual Property and Access to Medicines (15-17 January 2018)....
Read more about GSIPA2M: The Summit Highlights
IP and access to medicines: welcome speech
Our inaugural Global Summit on Intellectual Property and Access to Medicines has started today. Read Solange Baptiste’s welcoming speech below,...
Read more about IP and access to medicines: welcome speech
New Study: Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
ITPC-MENA has released a comparative study of intellectual property provisions in Tunisia, Morocco and Egypt. The study was undertaken to...
Read more about New Study: Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
SURVEY: Help us become your go-to place on access to medicines
Will you take just 2-3 minutes so we can build a resource and a network that’s most useful for you?...
Read more about SURVEY: Help us become your go-to place on access to medicines
I-MAK challenges validity of remaining Hepatitis C drug patent
Legal challenge to unblock Hep C Treatment for up to 13 million people In a move that could strike down...
Read more about I-MAK challenges validity of remaining Hepatitis C drug patent